DRI Healthcare Trust (TSE:DHT.UN) Receives C$18.00 Average PT from Analysts

Shares of DRI Healthcare Trust (TSE:DHT.UN) have been assigned a consensus recommendation of “Moderate Buy” from the six research firms that are presently covering the company, MarketBeat reports. One analyst has rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 1-year price target among analysts that have updated their coverage on the stock in the last year is C$18.00.

DHT.UN has been the subject of several recent research reports. Scotiabank increased their target price on shares of DRI Healthcare Trust from C$21.00 to C$22.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 8th. Raymond James reduced their price objective on DRI Healthcare Trust from C$23.00 to C$22.00 in a research note on Wednesday, November 13th.

DRI Healthcare Trust Trading Up 48.9 %

Shares of TSE:DHT.UN opened at C$12.95 on Thursday. DRI Healthcare Trust has a 1-year low of C$10.39 and a 1-year high of C$17.43. The firm has a fifty day moving average price of C$13.41 and a 200 day moving average price of C$13.37.

DRI Healthcare Trust Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, October 18th. Investors of record on Friday, October 18th were issued a $0.085 dividend. This represents a $0.34 dividend on an annualized basis and a dividend yield of 2.63%. The ex-dividend date was Friday, September 27th. DRI Healthcare Trust’s dividend payout ratio is currently -920.00%.

About DRI Healthcare Trust

DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headquartered in Toronto, Canada.